2015-04-30 18:27:42 UTC

New Hepatitis Treatment Cost Effective for Some Patient Types

April 27, 2015

For HCV patients with cirrhosis and for those without cirrhosis who have failed other treatments, new treatment regimens may be cost effective.

For individuals infected with hepatitis C virus (HCV), new regimens are highly effective, but also very expensive, at approximately $28,000 for four weeks of treatment. This pricey treatment is cost effective for HCV patients with cirrhosis and for those without cirrhosis who have failed other treatments, according to a study published in Annals of Internal Medicine.

Read more about these findings in GI & Hepatology News.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.